Brazil’s Anvisa says Janssen files for emergency use of its COVID-19 shot
By Krishna N. DasPosted on
FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed J&J logo in this illustration
RIO DE JANEIRO (Reuters) – Brazil’s federal health regulator Anvisa said on Wednesday that Janssen had filed for emergency use authority for its COVID-19 vaccine developed by Johnson & Johnson.
(Reporting by Pedro Fonseca; Editing by Chris Reese)